Condition
Malignant Mesothelioma
Estimated Enrollment: 29
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: MESOT-TREM-2012|2012-002762-12
Study First Received: July 31, 2012
Last Updated: July 31, 2012
Estimated Primary Completion Date: January 2014
Primary Outcome Measures:
To determine the objective response|Disease control rate (DCR)|Safety|Progression free survival
Sponsors and Collaborators:
Azienda Ospedaliera Universitaria Senese|MedImmune LLC
Website Link: https://ClinicalTrials.gov/show/NCT01655888
